Ultragenyx Pharmaceutical Inc.
Rare-disease biotech with multiple commercial medicines and late-stage biologic, gene-therapy and ASO programs.
Rare genetic disease · Biologics, gene therapy, ASO & small molecules · Commercial + Phase 3
Rare-disease biotech with multiple commercial medicines and late-stage biologic, gene-therapy and ASO programs.
Rare genetic disease · Biologics, gene therapy, ASO & small molecules · Commercial + Phase 3